QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,174 signal articles · 357 in last 24h · 110,767 total before filter · latest 47m ago
357last 24h
2376last 7d
428● bullish (7d)
221● bearish (7d)
202publishers
AllMacro259Earnings1445M&A99Regulatory17Product17Analyst22
✕ clear all filtersticker: CAVASentiment:bullishneutralbearish✓ showing all (incl. clickbait)
CAVA Group (CAVA) Stock Sees Modest Fair Value Lift After Mixed Analyst Views
Simply Wall St.33d agoneutral
CAVA Group (CAVA) Stock Sees Modest Fair Value Lift After Mixed Analyst Views

The fair value estimate for CAVA Group has shifted from US$87.27 to US$92.88, signaling an updated view of what analysts see as a reasonable anchor for the stock. This change comes as recent research balances strong same-store sales, unit expansion, and brand momentum against concerns that a premium price may already factor in much of that optimism. In the sections ahead, you will see how this revised fair value fits into the evolving CAVA Group narrative and what to watch as sentiment...

CAVA (CAVA) Stock Still Looks Pricey As Its 3 Year Return Holds
Simply Wall St.34d agoneutral
CAVA (CAVA) Stock Still Looks Pricey As Its 3 Year Return Holds

CAVA Group stock has rebounded over the last three years, yet recent price weakness and a low overall value score suggest the shares may still be carrying a valuation premium rather than offering a clear margin of safety. CAVA Group has returned about 30% over the past three years. This keeps longer term holders in positive territory even though more recent periods have seen the share price decline. Growth expectations tied to continued store expansion and revenue gains can support a fuller...

CAVA Group (CAVA) Could Be 6% Overvalued Ahead Of Earnings
Simply Wall St.34d agoneutral
CAVA Group (CAVA) Could Be 6% Overvalued Ahead Of Earnings

Recent Stock Weakness and Earnings Anticipation CAVA Group (CAVA) has recently seen its stock decline and lag the broader market and its sector, as investors turn attention to the company’s upcoming earnings report and what it may imply for future performance. See our latest analysis for CAVA Group. At a share price of $69.74, CAVA Group’s short term momentum has cooled, with the share price down 3.02% over one day and 11.14% over seven days. Its year to date share price return of 15.18%...

Jersey Mike’s Stacks Up Profit Prior to IPO
The Wall Street Journal40d agoneutral
Jersey Mike’s Stacks Up Profit Prior to IPO

Jersey Mike's profits shot up last year, though the sandwich chain said that sales growth has been mixed in recent months as it gears up for a potential public offering this year. The New Jersey-based sub sandwich maker said Thursday in its initial registration filing that net income jumped to $55 million in its 2025 fiscal year, up from $5 million the year before, due to more royalties and lower founder-related discretionary expenses. New marketing and a chicken salad offering have helped in June, the chain said.

Wall Street Analysts Look Bullish on Cava (CAVA): Should You Buy?
Zacks42d agobullish
Wall Street Analysts Look Bullish on Cava (CAVA): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in Cava (CAVA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Why CAVA Group (CAVA) Is Down 6.6% After Sector-Wide Restaurant Stock Pullback And What's Next
Simply Wall St.48d agoneutral
Why CAVA Group (CAVA) Is Down 6.6% After Sector-Wide Restaurant Stock Pullback And What's Next

CAVA Group’s recent momentum in traffic growth, menu expansion and new restaurant openings has been tested by a sector-wide pullback across restaurant stocks in late June 2026, reflecting broader industry worries rather than a company-specific setback. Despite these crosscurrents, CAVA’s record past-year revenue above US$1.00 billion and continued health-focused, experience-led positioning underline how company fundamentals can diverge from short-term sector sentiment. We’ll now examine how...